GLP-1 Data Library
The first truly multimodal real-world clinical dataset purpose-built to capture the underlying biology of cardiometabolic diseases, including the role of GLP-1s in treatment
Highlights
Access multimodal clinical data about GLP-1 users and matched controls
Our data go deep: drawing in imaging, waveforms, notes, pathology, and videos linked to long-term outcomes from the EHR
-
210K+ individuals on a GLP-1 and 300K+ available matched controls
-
Longitudinal data capture of all health system data - we mean ALL the data - beginning in 2016
-
Sourced from three large representative health systems from three different regions covering 10M+ lives; includes large populations from underrepresented communities
-
Unstructured modalities (imaging, waveforms, video and pathology) labeled with AI / ML to capture biology at scale
-
Compliant data curation processes and documentation; ability to demonstrate data are fit for purpose
Use Cases
-
Example: compare two on-market GLP-1s in terms of reduction in liver fat percentage as revealed through CT scans
-
Example: explore benefits of GLP-1 use on cardiac function as captured in ECG reports for individuals originally treated for obesity
-
Example: demonstrate the quality of weight loss from GLP-1 use by quantifying any changes in muscle composition as revealed via CTs
-
Example: pair unstructured data sources with large quantities of phenotypic labels to develop algorithms that increase diagnosis of relevant conditions and match patients to a specific treatment
-
Example: explore the journey of patients who are prescribed a GLP-1 for obesity both prior to and following treatment initiation; identify common barriers to treatment initiation, persistence, and adherence
